Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
NAR Molecular Medicine|November 25, 2024
Systematic deletion of symmetrical CFTR exons reveals new therapeutic targets for exon skipping antisense oligonucleotidesCecilia Pena-Rasgado, Elvia Rodriguez-Manriquez, Miroslav Dundr, et al.
NAR Molecular Medicine|March 14, 2025
Nucleotide level mapping of uracils in murine heavy chain switch regions shows correlation between uracilation and positions of switch junctions created during class-switch recombinationRukshana Mohamad-Ramshan, Ramin Sakhtemani, Yasha Butt, et al.
NAR Molecular Medicine|October 3, 2024
The role of RAD51 regulators and variants in primary ovarian insufficiency, endometriosis, and polycystic ovary syndromeMaggie Witham, Sarah R Hengel
NAR Molecular Medicine|June 24, 2024
A small molecule that inhibits the evolution of antibiotic resistanceJuan Carvajal-Garcia, Harrison Bracey, Anna E Johnson, et al.
NAR Molecular Medicine|May 23, 2024
Frequencies and spectra of aflatoxin B1-induced mutations in liver genomes of NEIL1-deficient mice as revealed by duplex sequencingIrina G Minko, Michael M Luzadder, Vladimir L Vartanian, et al.
NAR Molecular Medicine|January 19, 2026
A therapeutic antisense oligonucleotide encompassing 2'-O-methoxyethyl modification triggers unique perturbation of the transcriptomeEric W Ottesen, Wren A Murzyn, Robert L Kaas, et al.
NAR Molecular Medicine|January 26, 2026
Systemic distribution of tricyclo-DNA antisense oligonucleotide following intratracheal instillation in the mouseJérémy Laurent, Therese B Deramaudt, Romane Cloix, et al.
NAR Molecular Medicine|November 27, 2025
The adaptability of the fungal tRNA ligase's ATP-binding pocket: a potential target for new antifungal drugsAlastair G McEwen, Alessandro Giovinazzo, Pierre Poussin-Courmontagne, et al.
NAR Molecular Medicine|November 21, 2025
Investigation of the PIWI-interacting RNA expression differences in normoresponder and diminished ovarian reserve follicular fluidÇağrı Öner, Zafer İşdar, Nergis Özlem Kiliç, et al.
NAR Molecular Medicine|November 21, 2025
Oligonucleotides targeting the 3' splice site downstream of a microexon as an innovative therapy for autismAinhoa Martinez-Pizarro, Sara Picó, Mar Alvárez, et al.
Pageof 12